BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12659676)

  • 1. Ultrasound-guided percutaneous delivery of adenoviral vectors encoding the beta-galactosidase and human factor IX genes to early gestation fetal sheep in utero.
    David A; Cook T; Waddington S; Peebles D; Nivsarkar M; Knapton H; Miah M; Dahse T; Noakes D; Schneider H; Rodeck C; Coutelle C; Themis M
    Hum Gene Ther; 2003 Mar; 14(4):353-64. PubMed ID: 12659676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful expression of beta-galactosidase and factor IX transgenes in fetal and neonatal sheep after ultrasound-guided percutaneous adenovirus vector administration into the umbilical vein.
    Themis M; Schneider H; Kiserud T; Cook T; Adebakin S; Jezzard S; Forbes S; Hanson M; Pavirani A; Rodeck C; Coutelle C
    Gene Ther; 1999 Jul; 6(7):1239-48. PubMed ID: 10455432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained delivery of therapeutic concentrations of human clotting factor IX--a comparison of adenoviral and AAV vectors administered in utero.
    Schneider H; Mühle C; Douar AM; Waddington S; Jiang QJ; von der Mark K; Coutelle C; Rascher W
    J Gene Med; 2002; 4(1):46-53. PubMed ID: 11828387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the respiratory muscles of fetal sheep for prenatal gene therapy for Duchenne muscular dystrophy.
    Weisz B; David AL; Gregory LG; Perocheau D; Ruthe A; Waddington SN; Themis M; Cook T; Coutelle C; Rodeck CH; Peebles DM
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1105-9. PubMed ID: 16157120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep.
    David AL; McIntosh J; Peebles DM; Cook T; Waddington S; Weisz B; Wigley V; Abi-Nader K; Boyd M; Davidoff AM; Nathwani AC
    Hum Gene Ther; 2011 Apr; 22(4):419-26. PubMed ID: 20919876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAPS Prize--1997. Fetal gene therapy: efficacy, toxicity, and immunologic effects of early gestation recombinant adenovirus. British Association of Paediatric Surgeons.
    Yang EY; Cass DL; Sylvester KG; Wilson JM; Adzick NS
    J Pediatr Surg; 1999 Feb; 34(2):235-41. PubMed ID: 10052795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic plasma concentrations of human factor IX in mice after gene delivery into the amniotic cavity: a model for the prenatal treatment of haemophilia B.
    Schneider H; Adebakin S; Themis M; Cook T; Douar AM; Pavirani A; Coutelle C
    J Gene Med; 1999; 1(6):424-32. PubMed ID: 10753068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sheep model of in utero gene therapy.
    Porada CD; Park P; Almeida-Porada G; Zanjani ED
    Fetal Diagn Ther; 2004; 19(1):23-30. PubMed ID: 14646413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonographic development of the fetal sheep stomach and evaluation of early gestation ultrasound-guided in utero intragastric injection.
    David AL; Abi-Nader KN; Weisz B; Shaw SW; Themis M; Cook T; Coutelle C; Rodeck CH; Peebles DM
    Taiwan J Obstet Gynecol; 2010 Mar; 49(1):23-9. PubMed ID: 20466288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
    Bouchard S; MacKenzie TC; Radu AP; Hayashi S; Peranteau WH; Chirmule N; Flake AW
    J Gene Med; 2003 Nov; 5(11):941-50. PubMed ID: 14601131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In utero gene transfer of human factor IX to fetal mice can induce postnatal tolerance of the exogenous clotting factor.
    Waddington SN; Buckley SM; Nivsarkar M; Jezzard S; Schneider H; Dahse T; Kemball-Cook G; Miah M; Tucker N; Dallman MJ; Themis M; Coutelle C
    Blood; 2003 Feb; 101(4):1359-66. PubMed ID: 12393743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero.
    Chen XG; Zhu HZ; Gong JL; Li F; Xue JL
    Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine gene transfer: gestational stage-specific gene delivery in mice.
    Türkay A; Saunders T; Kurachi K
    Gene Ther; 1999 Oct; 6(10):1685-94. PubMed ID: 10516717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.
    Ge Y; Powell S; Van Roey M; McArthur JG
    Blood; 2001 Jun; 97(12):3733-7. PubMed ID: 11389010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors.
    Mitchell M; Jerebtsova M; Batshaw ML; Newman K; Ye X
    Gene Ther; 2000 Dec; 7(23):1986-92. PubMed ID: 11175309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: toward prenatal prevention of early-onset intestinal diseases.
    David AL; Peebles DM; Gregory L; Waddington SN; Themis M; Weisz B; Ruthe A; Lawrence L; Cook T; Rodeck CH; Coutelle C
    Hum Gene Ther; 2006 Jul; 17(7):767-79. PubMed ID: 16839275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widespread and efficient marker gene expression in the airway epithelia of fetal sheep after minimally invasive tracheal application of recombinant adenovirus in utero.
    Peebles D; Gregory LG; David A; Themis M; Waddington SN; Knapton HJ; Miah M; Cook T; Lawrence L; Nivsarkar M; Rodeck C; Coutelle C
    Gene Ther; 2004 Jan; 11(1):70-8. PubMed ID: 14681699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA.
    Nathwani AC; Davidoff A; Hanawa H; Zhou JF; Vanin EF; Nienhuis AW
    Blood; 2001 Mar; 97(5):1258-65. PubMed ID: 11222368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraamniotic administration of an adenoviral vector for gene transfer to fetal sheep and mouse tissues.
    Holzinger A; Trapnell BC; Weaver TE; Whitsett JA; Iwamoto HS
    Pediatr Res; 1995 Dec; 38(6):844-50. PubMed ID: 8618783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.